4
Changes in Ownership
PALISADE BIO, INC. Filed Acc 0001144204-13-021025
Options or other derivatives
- Chief Scientific Officer acquired 592,219 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
JOHE KARL · Chief Scientific Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2013-03-28 | Grant or award : show line 1 in the form Common Stock Purchase Option | +592,219 | $1.12 | 2023-03-28 | 592,219 | 592,219 | D |
Loading xslF345X03/v340927_4.xml…